A detailed history of Prudential PLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Prudential PLC holds 37,318 shares of RPRX stock, worth $941,533. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,318
Previous 123,524 69.79%
Holding current value
$941,533
Previous $3.26 Million 67.61%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$25.63 - $29.27 $2.21 Million - $2.52 Million
-86,206 Reduced 69.79%
37,318 $1.06 Million
Q2 2024

Aug 06, 2024

BUY
$26.26 - $29.9 $3.24 Million - $3.69 Million
123,524 New
123,524 $3.26 Million
Q4 2023

Feb 13, 2024

SELL
$26.21 - $29.22 $1.33 Million - $1.48 Million
-50,708 Reduced 78.36%
14,002 $393,000
Q3 2023

Nov 09, 2023

SELL
$26.26 - $31.38 $22,347 - $26,704
-851 Reduced 1.3%
64,710 $1.76 Million
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $1.94 Million - $2.4 Million
65,561 New
65,561 $2.02 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Prudential PLC Portfolio

Follow Prudential PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential PLC, based on Form 13F filings with the SEC.

News

Stay updated on Prudential PLC with notifications on news.